Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
1-Year Return
24.55%
This Quarter Return
-15%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$4.96B
AUM Growth
-$360M
(-6.8%)
Cap. Flow
+$506M
Cap. Flow
% of AUM
10.2%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
191
New
9
Increased
107
Reduced
41
Closed
24
Top Buys
| 1 |
Alibaba
BABA
|
$49.1M |
| 2 |
Abbott
ABT
|
$39.7M |
| 3 |
NetEase
NTES
|
$37.1M |
| 4 |
Pool Corp
POOL
|
$36.7M |
| 5 |
Service Corp International
SCI
|
$26.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$48.5M |
| 2 |
Bank OZK
OZK
|
$34.4M |
| 3 |
Meta Platforms (Facebook)
META
|
$20.4M |
| 4 |
XPO
XPO
|
$19.4M |
| 5 |
Owens Corning
OC
|
$12.5M |
Sector Composition
| 1 | Consumer Discretionary | 19.07% |
| 2 | Healthcare | 18.08% |
| 3 | Industrials | 14.01% |
| 4 | Financials | 13.7% |
| 5 | Technology | 13.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
151
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $2.93M | 0.06% |
404,143
-395,857
| -49% | -$2.87M |
|
152
Sarepta Therapeutics
SRPT
$1.96B
| $2.89M | 0.06% |
26,500
-6,000
| -18% | -$655K |
|
|
ARQL
153
DELISTED
Arqule Inc
ARQL
| $2.77M | 0.06% |
1,000,000
| – | – |
|
|
MYOK
154
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.59M | 0.05% |
53,000
-10,000
| -16% | -$489K |
|
|
JKS
155
JinkoSolar
JKS
$1.32B
| $2.34M | 0.05% |
236,536
+79,692
| +51% | +$788K |
|
|
FOMX
156
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.3M | 0.05% |
640,000
| – | – |
|
157
Nektar Therapeutics
NKTR
$764M
| $2.11M | 0.04% |
4,269
+902
| +27% | +$445K |
|
158
Minerva Neurosciences
NERV
$16.4M
| $1.38M | 0.03% |
25,625
| – | – |
|
159
Sangamo Therapeutics
SGMO
$165M
| $1.09M | 0.02% |
95,000
-450,000
| -83% | -$5.17M |
|
160
Infosys
INFY
$67.9B
| $1.08M | 0.02% |
+113,200
| New | +$1.08M |
|
161
Yum China
YUMC
$16.5B
| $1.01M | 0.02% |
30,000
-5,000
| -14% | -$168K |
|
|
JOYY
162
JOYY Inc. American Depositary Shares
JOYY
$3.21B
| $880K | 0.02% |
14,700
| – | – |
|
163
HDFC Bank
HDB
$361B
| $829K | 0.02% |
+16,000
| New | +$829K |
|
164
Digimarc
DMRC
$181M
| $725K | 0.01% |
50,000
+36,300
| +265% | +$526K |
|
165
Teva Pharmaceuticals
TEVA
$21.7B
| $694K | 0.01% |
45,000
+22,500
| +100% | +$347K |
|
|
QIWI
166
DELISTED
QIWI PLC
QIWI
| $566K | 0.01% |
+40,000
| New | +$566K |
|
167
Robert Half
RHI
$3.77B
| $276K | 0.01% |
+4,818
| New | +$276K |
|
168
Accenture
ACN
$159B
| – | – |
-2,225
| Closed | -$379K |
|
169
AnaptysBio
ANAB
$613M
| – | – |
-16,000
| Closed | -$1.6M |
|
170
Badger Meter
BMI
$5.39B
| – | – |
-16,419
| Closed | -$869K |
|
171
Bristol-Myers Squibb
BMY
$96B
| – | – |
-51,060
| Closed | -$3.17M |
|
|
BPMC
172
DELISTED
Blueprint Medicines
BPMC
| – | – |
-19,000
| Closed | -$1.48M |
|
173
Brady Corp
BRC
$3.86B
| – | – |
-4,707
| Closed | -$206K |
|
174
Cigna
CI
$81.5B
| – | – |
-2,568
| Closed | -$535K |
|
175
Deere & Co
DE
$128B
| – | – |
-7,000
| Closed | -$1.05M |
|